s-ketamin pfizer stungulyf, lausn 25 mg/ml
pfizer aps - esketaminum hýdróklóríð - stungulyf, lausn - 25 mg/ml
columvi
roche registration gmbh - glofitamab - lymphoma, large b-cell, diffuse - Æxlishemjandi lyf - columvi as monotherapy is indicated for the treatment of adult patients with relapsed or refractory diffuse large b cell lymphoma (dlbcl), after two or more lines of systemic therapy.
talvey
janssen-cilag international n.v. - talquetamab - mergæxli - Æxlishemjandi lyf - talvey is indicated as monotherapy for the treatment of adult patients with relapsed and refractory multiple myeloma, who have received at least 3 prior therapies, including an immunomodulatory agent, a proteasome inhibitor, and an anti cd38 antibody and have demonstrated disease progression on the last therapy.
tepkinly
abbvie deutschland gmbh & co. kg - epcoritamab - lymphoma, large b-cell, diffuse - Æxlishemjandi lyf - tepkinly as monotherapy is indicated for the treatment of adult patients with relapsed or refractory diffuse large b-cell lymphoma (dlbcl) after two or more lines of systemic therapy.
ghryvelin (previously macimorelin aeterna zentaris)
atnahs pharma netherlands b.v. - macimorelin myndir - greiningaraðferðir, annarra - macimorelin - Þetta lyf er eingöngu ætlað til greiningar. ghryvelin is indicated for the diagnosis of growth hormone deficiency (ghd) in adults.
enalapril-hydrochlorthiazid krka tafla 20 mg /12,5 mg
krka sverige ab - enalaprilum maleat; hydrochlorothiazidum inn - tafla - 20 mg /12,5 mg
darazíð tafla 20 mg/12,5 mg
actavis group ptc ehf. - enalaprilum maleat; hydrochlorothiazidum inn - tafla - 20 mg/12,5 mg
syntocinon stungulyf, lausn 10 a.e./ml
alfasigma s.p.a. - oxytocinum inn - stungulyf, lausn - 10 a.e./ml
venlafaxin actavis hart forðahylki 150 mg
actavis group ptc ehf. - venlafaxinum hýdróklóríð - hart forðahylki - 150 mg
venlafaxin actavis hart forðahylki 75 mg
actavis group ptc ehf. - venlafaxinum hýdróklóríð - hart forðahylki - 75 mg